Podiatrists in Marietta, GA Accepting Medicare

39 Podiatrists found. Showing 1 - 20

Choice Podiatry Center, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 540 Powder Springs St Ste B6, Marietta, GA 30064 Phone: 770-702-8723    Fax: 770-702-8723

Robert I Heden, DPM Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 4439 Roswell Rd, Marietta, GA 30062 Phone: 770-977-8221    Fax: 770-977-8222

Choice Podiatry Center, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 540 Powder Springs St Ste B6, Marietta, GA 30064 Phone: 770-702-8723    Fax: 707-702-8809

Village Podiatry Group, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3515 Dallas Hwy Sw, Marietta, GA 30064 Phone: 770-499-0080    Fax: 770-499-0570

Charles R Haendel, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 55 Whitcher St Ne, Ste 450, Marietta, GA 30060 Phone: 770-590-4188    Fax: 770-590-4189

Village Podiatry Group Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1100 Johnson Ferry Rd Ste 375, Marietta, GA 30068 Phone: 770-273-8895

John C Haight, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 165 Vann St Ne, Marietta, GA 30060 Phone: 770-422-9856

Stephen L Barrett, DPM, FACFAS, MBA Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2520 Windy Hill Rd Se Ste 205, Marietta, GA 30067 Phone: 404-228-9892

East Cobb Foot & Ankle Care P.c. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 4439 Roswell Rd, Marietta, GA 30062 Phone: 770-977-8221    Fax: 770-977-8222

Dr. Ryan Goldfine, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 3451 Ernest W Barrett Pkwy Nw Ste 170, Marietta, GA 30064 Phone: 785-933-1276    Fax: 678-274-6348

Sequioa Ducasse, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2550 Windy Hill Rd Se Ste 206, Marietta, GA 30067 Phone: 404-833-3969    Fax: 404-228-9892

A Family Podiatry Center Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1234 Powers Ferry Rd, Suite 103, Marietta, GA 30067 Phone: 770-951-8976    Fax: 770-951-8988

Suzanne M Clous, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4329 Dover Crossing Dr, Marietta, GA 30066 Phone: 404-556-1710

Nichol Lynn Salvo, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2550 Windy Hill Road, Suite 104, Marietta, GA 30067 Phone: 770-952-2040    Fax: 770-988-0379

Dr. Anthony J Gatti, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 792 Church St, Ste 101, Marietta, GA 30060 Phone: 770-422-9856    Fax: 770-984-0303

Dr. Kinna Ashok Patel, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 540 Powder Springs St Ste B6, Marietta, GA 30064 Phone: 561-293-5288    Fax: 770-702-8809

Premier Podiatry-east Cobb Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1121 Johnson Ferry Rd, Building 1, Suite 215, Marietta, GA 30068 Phone: 770-693-0700

Matthew Ward, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 165 Vann St Ne, Marietta, GA 30060 Phone: 770-422-9856    Fax: 770-984-0303

Dr. Mark R. Light, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 4439 Roswell Rd, Marietta, GA 30062 Phone: 770-977-8221    Fax: 770-977-8222

Marietta Podiatry Group Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 165 Vann St Ne, Marietta, GA 30060 Phone: 770-422-9856    Fax: 770-984-0303

News Archive

Prometheus Laboratories, Bayer Schering Pharma form research collaboration and license agreement

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products.

Federal ban on use of antimicrobials in food animals will impact both animal and human health, says AVMA

The American Veterinary Medical Association (AVMA) today cautioned against federal bans on the judicious use of antimicrobials in animal agriculture.

Pseudobulbar affect impacts majority of stroke survivors, but few have any understanding of condition

A survey released today by National Stroke Association shows that 53 percent of stroke survivor respondents suffer from symptoms of another neurologic condition called pseudobulbar affect (PBA), a condition thought to be caused by structural damage in the brain due to injury or disease. PBA causes involuntary and unpredictable outbursts of laughing or crying, often in socially inappropriate situations. Even though a significant proportion of stroke survivors suffer from PBA, fewer than one in five are familiar with the condition.

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

To monitor antibody level duration of vaccine-induced immune responses, a team of researchers in the U.S. – at Diacarta, University of California and VA Healthcare System, and the Franciscan University of Steubenville – evaluated the feasibility of using a single drop of fingerstick blood collected with flocked swabs for quantitative antibody response evaluation after COVID-19 vaccination.

OXiGENE reports positive final data from Phase 1 study of OXi4503 in patients with solid tumors

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.

Read more Medical News

› Verified 5 days ago

• 1(current)
• 2